Combination therapy: A new strategy to manage diabetes and its complications

Phytomedicine

Volumn 21, Issue 2, 2014, Pages 123-130

  Prabhakar, P K ^a   Kumar, Anil ^b   Doble, Mukesh ^c  

^a LOVELY PROFESSIONAL UNIVERSITY   (India)

^b TATA Chemicals Ltd   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Combination; Diabetes; Isobologram; Phytochemicals; Synergy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ANTIDIABETIC AGENT; BERBERINE; CAFFEIC ACID; CHLOROGENIC ACID; CIGLITAZONE; CINNAMIC ACID; COUMARIC ACID; ENGLITAZONE; EUGENOL; EXENDIN 4; FERULIC ACID; GARLIC EXTRACT; GINSENG EXTRACT; GLIBENCLAMIDE; GLIBORNURIDE; GLIMEPIRIDE; GLIPIZIDE; HYPERICUM PERFORATUM EXTRACT; METFORMIN; METFORMIN PLUS PIOGLITAZONE; MOMORDICA CHARANTIA EXTRACT; NUTRACEUTICAL; PIOGLITAZONE; PLANT MEDICINAL PRODUCT; REPAGLINIDE; ROSIGLITAZONE; TROGLITAZONE;

ANTIDIABETIC ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; COMORBIDITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HERB DRUG INTERACTION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHARMACOKINETICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRADITIONAL MEDICINE;

COMBINATION; DIABETES; ISOBOLOGRAM; PHYTOCHEMICALS; SYNERGY;

DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HERB-DRUG INTERACTIONS; HUMANS; HYPOGLYCEMIC AGENTS; PHYTOCHEMICALS; PLANT EXTRACTS;

EID: 84892919148     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.08.020     Document Type: Article

References (65)

1. F.J. Alarcon-Aguilara, R. Roman-Ramos, S. Perez-Gutierrez, A. Aguilar-Contreras, C.C. Contreras-Weber, and J.L. Flores-Saenz Study of the anti-hyperglycemic effect of plants used as antidiabetics J. Ethnopharmacol. 61 2 1998 101 110
2. D.K. Andersson, and K. Svärdsudd Long-term glycemic control relates to mortality in type II diabetes Diabetes Care 18 12 1995 1534 1543
3. V. Bermúdez, F. Finol, N. Parra, M. Parra, A. Pérez, L. Peñaranda, D. Vílchez, J. Rojas, N. Arráiz, and M. Velasco PPAR-gamma agonists and their role in type 2 diabetes mellitus management Am. J. Ther. 17 3 2010 274 283
4. I.V. Bijnsdorp, E. Giovannetti, and G.J. Peters Analysis of drug interactions Methods Mol. Biol. 731 2011 421 434
5. P.D. Blanc, L. Trupin, G. Earnest, P.P. Katz, E.H. Yelin, and M.D. Eisner Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis: data from a population-based survey Chest 120 5 2001 1461 1467
6. A.Y.Y. Cheng, and I.G. Fantus Oral antihyperglycemic therapy for type 2 diabetes mellitus Can. Med. Assoc. J. 172 2 2005 213 226
7. G.Y. Chiou, and J.C. Fong Synergistic effect of prostaglandin F2α and cyclic AMP on glucose transport in 3T3-L1 adipocytes J. Cell. Biochem. 94 3 2005 627 634
8. S.K. Das, and S.C. Elbein The genetic basis of type 2 diabetes Cell Sci. 2 2006 100 131
9. E. De Sousa, L. Zanatta, I. Seifriz, T.B. Creczynski-Pasa, M.G. Pizzolatti, B. Szpoganicz, and F.R. Silva Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves J. Nat. Prod. 67 5 2004 829 832
10. R.A. DeFronzo, R.C. Bonadonna, and E. Ferrannini Pathogenesis of NIDDM: a balanced overview Diabetes Care 15 3 1992 318 368
11. L. Dey, A.S. Attele, and C.S. Yuan Alternative therapies for type 2 diabetes Altern. Med. Rev. 7 1 2002 45 58
12. J. Diaz-Delfin, M. Morales, and C. Caelles Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor I by inhibition of the c-Jun NH2-terminal kinase pathway Diabetes 56 7 2007 1865 1871
13. W. Duckworth Hyperglycemia and cardiovascular disease Curr. Atheroscler. Rep. 3 2001 383 391
14. J.C. Fong, C.C. Chen, D. Liu, M.S. Tu, S.P. Chai, and Y.S. Kao Synergistic effect of arachidonic acid and cyclic AMP on glucose transport in 3T3-L1 adipocytes Cell. Signal. 11 1 1999 53 58
15. J.C. Fong, Y.S. Kao, H.Y. Tsai, Y.Y. Chiou, and G.Y. Chiou Synergistic effect of endothelin-1 and cyclic AMP on glucose transport in 3T3-L1 adipocytes Cell. Signal. 16 7 2004 811 821
16. P.K. Gessner, and B.E. Cabana A study of the interaction of the hypnotic effects and of the toxic effects of chloral hydrate and ethanol J. Pharmacol. Exp. Ther. 174 1970 247 259
17. J.K. Grover, and V. Vats Shifting paradigm: from conventional to alternative medicines - an introduction on traditional indian medicines Asia Pacific Biotech. News 5 1 2001 28 32
18. J.K. Grover, and V. Vats Medicinal plants of India with anti-diabetic potential J. Ethnopharmacol. 81 1 2002 81 100
19. M.I. Harris, K.M. Flegal, C.C. Cowie, M.S. Eberhardt, D.E. Goldstein, R.R. Little, H.M. Wiedmeyer, and D.D. Byrd-Holt Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994 Diabetes Care 21 4 1998 518 524
20. S. Hemaiswarya, and M. Doble Synergistic interaction of eugenol with antibiotics against gram negative bacteria Phytomedicine 16 2009 997 1005
21. S. Hemaiswarya, and M. Doble Synergistic interaction of phenylpropanoids with antibiotics against bacteria J. Med. Microbiol. 59 2010 1469 1476
22. S. Hemaiswarya, A.K. Kruthiventi, and M. Doble Synergism between natural products and antibiotics against infectious diseases Phytomedicine 15 8 2008 639 652
23. N. Inamdar, S. Edalat, V. Kotwal, and S. Pawar Care with nature's cure: herbal drugs Phcog Rev. 1 2 2007 361 368
24. S. Jain, and S. Saraf Type 2 diabetes mellitus - its global prevalence and therapeutic strategies Diab. Met. Syndr.: Clin. Res. Rev. 4 2010 48 56
25. L. Jovanovic, D.R. Hassman, B. Gooch, R. Jain, S. Greco, N. Khutoryansky, and P.M. Hale Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone Diabetes Res. Clin. Pract. 63 2 2004 127 134
26. J.U. Junghanns, and R.H. Müller Nanocrystal technology, drug delivery and clinical applications Int. J. Nanomed. 3 3 2008 295 309
27. R. Kahn Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 7 1997 1183 1197
28. E.K. Kalra Nutraceutical-definition and introduction AAPS PharmSci 5 3 2003 E25 E26
29. N.A. Kelsey, H.M. Wilkins, and D.A. Linseman Nutraceutical antioxidants as novel neuroprotective agents Molecules 15 11 2010 7792 7814
30. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 9 1998 1414 1431
31. Y. Lin, and Z. Sun Current views on type II diabetes J. Endocrinol. 204 1 2010 1 11
32. S. Loewe The problem of synergism and antagonism of combined drugs Arzneimittelforschung 3 6 1953 285 290
33. S. Loewe Antagonisms and antagonists Pharmacol. Rev. 9 2 1957 237 242
34. R.A. Manek, N.R. Sheth, J.D. Vaghasiya, S.V. Malaviya, N.P. Jivani, and J.R. Chavda Study on herb-herb interaction potential of Glycyrrhiza glabra with Solanum xanthocarpum and Adhatoda vasica on mast cell stabilizing activity Int. J. Pharmacol. 7 2011 589 598
35. E.A. Mazzio, F. Close, and K.F.A. Soliman The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease Int. J. Mol. Sci. 12 1 2011 506 569
36. J.S. Moyers, T.L. Shiyanova, F. Mehrbod, J.D. Dunbar, T.W. Noblitt, K.A. Otto, A. Reifel-Miller, and A. Kharitonenkov Molecular determinants of FGF-21 activity - synergy and cross-talk with PPARγ signaling J. Cell. Physiol. 210 1 2007 1 6
37. S.N. Nivitabishekam, M. Asad, and V.S. Prasad Pharmacodynamic interaction of Momordica charantia with rosiglitazone in rats Chem. Biol. Interact. 177 3 2009 247 253
38. J.C. O' Connor, and G.G. Freund Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake Metabolism 52 6 2003 666 674
39. E.A. Omar, A. Kam, A. Alqahtani, K.M. Li, V. Razmovski-Naumovski, S. Nammi, K. Chan, B.D. Roufogalis, and G.Q. Li Herbal medicines and nutraceuticals for diabetic vascular complications: mechanisms of action and bioactive phytochemicals Curr. Pharm. Design 16 2010 3776 3807
40. P.K. Prabhakar, and M. Doble Mechanism of action of medicinal plants towards diabetes mellitus - a review J.N. Govil, V.K. Singh, R. Bhardwaj, Recent Progress in Medicinal Plants vol. 22 2008 Studium Press, LLC USA 187 210
41. P.K. Prabhakar, and M. Doble A target based therapeutic approach towards diabetes mellitus using medicinal plants Curr. Diabetes Rev. 4 4 2008 291 308
42. P.K. Prabhakar, and M. Doble Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes Phytomedicine 16 12 2009 1119 1126
43. P.K. Prabhakar, and M. Doble Effect of natural products on commercial oral antidiabetic drugs in enhancing 2-deoxyglucose uptake by 3T3-L1 adipocytes Ther. Adv. Endocrinol. Metab. 2 3 2011 103 114
44. P.K. Prabhakar, and M. Doble Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adipocytes J. Agric. Food Chem. 59 18 2011 9835 9844
45. P.K. Prabhakar, and M. Doble Interaction of phytochemicals with hypoglycemic drugs on glucose uptake in L6 myotubes Phytomedicine 18 4 2011 285 291
46. P.K. Prabhakar, R. Prasad, S. Ali, and M. Doble Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats Phytomedicine 20 6 2013 488 494
47. Reddy, J.S., Dandela, R., Viswanadha, G.S., Nagalapalli, R., Solomon, A, K., Javed, I., Kruthiventi, A.K., 2011. Metformin and a-amino acids. WO2011051974 A1.
48. R.P. Robertson Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes J. Biol. Chem. 279 2004 42351 42354
49. T. Sandouk, D. Reda, and C. Hofmann Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells Am. J. Physiol. Cell Physiol. 264 6 Pt 1 1993 C1600 C1608
50. T. Sandouk, D. Reda, and C. Hofmann The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability Endocrinology 133 1 1993 352 359
51. K.E. Schemmel, R.S. Padiyara, and J.J. D'Souza Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review J. Diab. Complicat. 24 5 2010 354 360
52. S. Schwartz Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide Curr. Med. Res. Opin. 24 11 2008 3009 3022
53. G.M. Shenfield Drug interactions with oral hypoglycemic drugs Aust. Prescr. 24 4 2001 83 85
54. M. Stumvoll, B.J. Goldstein, and T.W. Van Haeften Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 9467 2005 1333 1346
55. D. Szalkowski, S. White-Carrington, J. Berger, and B. Zhang Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells Endocrinology 136 4 1995 1474 1481
56. R.J. Tallarida Drug synergism: its detection and applications J. Pharmacol. Exp. Therapeut. 298 3 2001 865 872
57. C. Ting-Chao Drug combination studies and their synergy quantification using the Chou-Talalay method Cancer Res. 70 2010 440 446
58. A.K. Tiwari, and J.M. Rao Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects Curr. Sci. 83 1 2002 30 38
59. H. Wagner, and G. Ulrich-Merzenich Synergy research: Approaching a new generation of phytopharmaceuticals Phytomedicine 16 2-3 2009 97 110
60. F.R. Weiner, A. Shah, P.J. Smith, C.S. Rubin, and M.A. Zern Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha Biochemistry 28 9 1989 4094 4099
61. E.M. Williamson Synergy and other interactions in phytomedicines Phytomedicine 8 5 2001 401 409
62. A.J.J. Wood, and P.A.G.M. De Smet Herbal Remedies New Engl. J. Med. 347 25 2002 2046 2056
63. H. Xu, K.M. Williams, W.S. Liauw, M. Murray, R.O. Day, and A.J. Mclachlan Effects of St John's wort and Cyp2c9 genotype on the pharmaco-kinetics and pharmacodynamics of gliclazide Br. J. Pharmacol. 153 2008 1579 1586
64. L. Zhao, M.G. Wientjes, and J.L.S. Au Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses Clin. Cancer Res. 10 23 2004 7994 8004
65. P. Zimmet Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J. Intern. Med. 247 3 2000 301 310